Position in NTRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$390,888
+$102,903 QoQ
Shares Held
1,440
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#570
of 844 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Knollwood Investment Advisory, LLC holds $10,555,386 across 7 Diagnostics & Research names. NTRA ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
5,800 | $3,053,352 | |
| 2 | A |
Agilent Technologies, Inc.
|
19,373 | $2,573,315 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
1,910 | $2,440,044 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
3,180 | $1,594,324 | |
| 5 | NTRA |
Natera, Inc.
This page
|
1,440 | $390,888 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
525 | $278,034 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
994 | $225,429 |
All Filings in NTRA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $390,888 | 1,440 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $287,985 | 1,440 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $329,889 | 1,440 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $231,796 | 1,440 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $253,410 | 1,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $212,115 | 1,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $237,450 | 1,500 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||